Heather Self
Nurse Practitioner · Macon, GANPI 1336611714
Payments from drug & device makers
Across 321 payments — averaging $25.21 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$2K
- Amgen$1K
- Aurinia Pharma U.S., Inc.$947
- Otsuka America Pharmaceutical, Inc.$501
- Mallinckrodt Hospital Products Inc.$455
- Travere Therapeutics, Inc.$454
- plus $3K from 21 others
What the payments were for
- Food & beverage$7,77796%
- Education$3144%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca(2 entities) | 48 | $1,506 |
| Amgen(2 entities) | 42 | $1,216 |
| Aurinia Pharma U.S., Inc. | 49 | $947 |
| Otsuka America Pharmaceutical, Inc. | 20 | $501 |
| Mallinckrodt Hospital Products Inc. | 9 | $455 |
| Travere Therapeutics, Inc. | 23 | $454 |
| Bayer | 27 | $436 |
| Daiichi Sankyo Inc. | 17 | $396 |
| Vifor Pharma, Inc. | 18 | $367 |
| Ardelyx, Inc. | 10 | $312 |
| Akebia Therapeutics Inc | 8 | $279 |
| Novartis | 10 | $222 |
| Baxter Healthcare | 2 | $205 |
| GSK | 9 | $152 |
| Scpharmaceuticals Inc. | 2 | $135 |
| Fresenius USA Marketing, Inc. | 6 | $104 |
| Calliditas Therapeutics US Inc. | 4 | $87 |
| Alnylam Pharmaceuticals Inc. | 4 | $80 |
| Xeris Pharmaceuticals, Inc. | 3 | $59 |
| Novo Nordisk | 2 | $40 |
| Apellis Pharmaceuticals, Inc. | 2 | $32 |
| EMD Serono, Inc. | 1 | $28 |
| Boston Scientific | 1 | $18 |
| Fresenius USA Manufacturing, Inc. | 1 | $18 |
| Seqirus USA Inc | 1 | $16 |
| E.r. Squibb & Sons, L.L.C. | 1 | $13 |
| Johnson & Johnson | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- LUPKYNIS$350
- FARXIGA$235
- KRYSTEXXA$232
- XPHOZAH 30 MG$148
- Vafseo$125
- LOKELMA$125
- Renal - PD$113
- ACTHAR$111
- FUROSCIX$110
How this compares
$8,092 in reported general payments places this provider in the 95th percentile of 3,328 nurse practitioner providers in Georgia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Potassium Chloride | 39 | $787 |
| Bumetanide | 14 | $447 |
| Metolazone | 11 | $298 |
| Famotidine | 21 | $280 |
| Losartan Potassium | 25 | $215 |
| Furosemide | 46 | $171 |
| Ciprofloxacin Hcl | 34 | $137 |
| Hydralazine Hcl | 12 | $137 |
| Amlodipine Besylate | 24 | $134 |
| Allopurinol | 16 | $132 |
| Hydrochlorothiazide | 17 | $131 |
| Telmisartan | 11 | $113 |
| Metoprolol Succinate | 12 | $112 |
| Carvedilol | 16 | $99 |
Paid to pharmacies, not to this prescriber.
Other nurse practitioner in Macon
- Jennifer StanfieldMacon$15K
- Amber WilsonMacon$12K
- Staci BennettMacon$12K
- Ashley VinsonMacon$11K
- Crystal LogsdonSavannah$566K
- Victor CzerkasijDalton$505K
- Kennon Mc CollumStockbridge$364K
- Pamela AllenRome$270K
- Tajuana BradleyJohns Creek$256K
- Janice McAlisterAtlanta$241K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.